MENU
ACRV
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Acrivon Therapeutics (ACRV) Earnings Date & Reports

Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform... Show more

A.I. Advisor
published Earnings

ACRV is expected to report earnings to rise 68.33% to -100 cents per share on May 13

Acrivon Therapeutics ACRV Stock Earnings Reports
Q1'25
Est.
$-1.01
Q4'24
Beat
by $0.17
Q3'24
Beat
by $0.15
Q2'24
Beat
by $0.23
Q1'24
Beat
by $0.06
The last earnings report on March 27 showed earnings per share of -60 cents, beating the estimate of -76 cents. With 85.85K shares outstanding, the current market capitalization sits at 54.55M.
View a ticker or compare two or three
ACRV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
480 Arsenal Way
Phone
+1 617 207-8979
Employees
61
Web
https://www.acrivon.com